| E-Folder |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Team Building > Team Building Survey Reveals Clues, Not Answers |
|
E-Folder - Team Building Survey Reveals Clues, Not Answers
Team Building Question: I’m a manager of a team of 20 people According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product and here is my question. At this year’s survey, the results ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in how that my team members don’t think their colleagues (from m lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. section and from other sections) often act on their own init here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ative. I would like to know what are the best ways to encoura d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro e team members to take initiative. Also, are you aware of any ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc road blocks that would prevent employees to take initiative easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi The Team Doc Says… Definition of scope, boundaries, author nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ty and autonomy are a must for people to take initiative. Int and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ restingly, during surveys people many times perceive that it’ ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi the other person who is not taking enough initiative — never ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a themselves. Yet if you received a lot of answers like this o dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod the survey, there may be another underlying problem. You’ll cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ave to dig to find out what that is. I recommend that you me tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen t with your team to discuss the results of the survey and ask t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel for their suggestions. That’s one way to “get some initiative ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust going!” Next meet with each team member individually to disc y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ss their personal goals and any road blocks they are encounte . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ing. Open (and often) communication with your team will help elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip you identify what may be causing this type of survey response tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Hiring A Public Relationship Firm Vending Business Opportunities Have Two Great Myths Strategic Planning: A Must for All Organisations
|